Literature DB >> 22797454

Use of emerging lipoprotein risk factors in assessment of cardiovascular risk.

Scott M Grundy.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22797454     DOI： 10.1001/jama.2012.6896

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

Review 1.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

2.  Hydroalcoholic Extract of Sechium edule Fruits Attenuates QT Prolongation in High Fat Diet-Induced Hyperlipidemic Mice.

Authors:  Firdous Sayed Mohammed; Arya Ghosh; Sourav Pal; Chayan Das; Suliman Yousef Alomar; Mohsina Patwekar; Faheem Patwekar; Byong-Hun Jeon; Fahadul Islam
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-11       Impact factor: 2.650

Review 3.  Hyperlipidemia as a risk factor for cardiovascular disease.

Authors:  Robert H Nelson
Journal:  Prim Care       Date:  2012-12-04       Impact factor: 2.907

4.  New Piece in the Jigsaw Puzzle: Adipose Tissue-Derived Stem Cells From Obese Subjects Drive Th17 Polarization.

Authors:  Balázs Csóka; Pál Pacher; Péter Bai; György Haskó
Journal:  Diabetes       Date:  2015-07       Impact factor: 9.461

5.  A2B adenosine receptors prevent insulin resistance by inhibiting adipose tissue inflammation via maintaining alternative macrophage activation.

Authors:  Balázs Csóka; Balázs Koscsó; Gábor Töro; Endre Kókai; László Virág; Zoltán H Németh; Pál Pacher; Péter Bai; György Haskó
Journal:  Diabetes       Date:  2013-11-05       Impact factor: 9.461

Review 6.  Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.

Authors:  Alexander N Orekhov; Yuri V Bobryshev; Igor A Sobenin; Alexandra A Melnichenko; Dimitry A Chistiakov
Journal:  Int J Mol Sci       Date:  2014-07-21       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.